Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Atif Irfan Khan"'
Autor:
Zoia Ehsan Khattak, Hamza Hashmi, Sana Irfan Khan, Atif Irfan Khan, Alicia Darwin, Faiz Anwer, Jack Khouri, Uroosa Arif, Arun D. Singh, Sobia Aamir
Publikováno v:
Annals of Hematology. 100:2155-2172
Multiple myeloma (MM) remains an incurable disease with the majority of patients experiencing disease relapse despite response to initial therapy. Antibody-drug conjugates (ADCs) and bispecific T-cell engagers are innovative immunotherapeutic approac
Autor:
Muhammad Ashar Ali, Usman Akbar, Anum Waqar, Muhammad Talha Liaquat, Faiz Anwer, Anam Khan, Muhammad Ammar Yaser, Atif Irfan Khan, Sobia Aamir, Saad Ur Rahman
Publikováno v:
Blood. 136:7-9
Background: Acute lymphoblastic leukemia (ALL) is rare but aggressive. For refractory and relapsed ALL (R/R ALL), various treatment strategies are adopted, of which the use of blinatumomab has shown promising results in recent decades. Blinatumomab i
Autor:
Keren Thankam Sam, Anam Khan, Muhammad Ashar Ali, Arooj Devi, Muhammad Asad, Mahwish Farrukh, Wajeeha Aiman, Nayha Tahir, Atif Irfan Khan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S345-S346
Context: Luspatercept is an erythroid maturation agent that has been shown to improve anemia by influencing late-onset erythropoiesis. Objective: To determine safety and efficacy of luspatercept in patients aged >18 years of age and diagnosed with ei
Autor:
Neeti Makhija, Atif Irfan Khan, Ramakrishnan Lakshmy, Anjali Hazarika, Gopal Kumar Patidar, Sachin Talwar
Publikováno v:
Transfusion medicine (Oxford, England)REFERENCES. 30(6)
OBJECTIVES In this study, we aimed to determine the consequences of different amounts of leukocyte transfusion on the outcome of patients undergoing cardiac surgery. DESIGN This was a prospective, single-blinded cohort study conducted for 1 year from
Autor:
Sara Ashraf, Anam Khan, Faiz Anwer, Karthi Vignesh Raj K, Fatima Sajid, Usman Ali Akbar, Atif Irfan Khan, Padma Sri Katikaneni, Ayesha Habib, Keren Sam
Publikováno v:
Blood. 138:4156-4156
Background Anemia in chronic kidney disease (CKD) patients develop primarily due to iron and erythropoietin deficiency, factors contributing to this include uremia induced inhibition of erythropoiesis, shortened red cell survival and nutritional defi
Autor:
Sobia Aamir, Atif Irfan Khan, Muhammad Arslan, Keren Sam, Muhammad Asad, Faiz Anwer, Fatima Sajid, Yusra Minahil Nasir, Anam Khan
Publikováno v:
Blood. 138:4155-4155
Background Anemia in inflammatory bowel disease (IBD) presents as a common extraintestinal manifestation resulting in many complications. This condition is often missed or underrated, anemia is secondary to blood loss or defective absorption of iron
Autor:
Syed Adeel Hassan, Usman Ali Akbar, Saman Bahram, Sudeep Yadav, Vivek Soorya Sathya Moorthy, Adnan Mehboob Qureshi, Sheref A Elseidy, Atif Irfan Khan, Faiz Anwer
Publikováno v:
Blood. 138:4215-4215
Introduction Immune thrombocytopenic purpura (ITP) is an autoimmune disorder consisting of low platelet count, purpura, and hemorrhagic episodes, caused by antiplatelet autoantibodies. Children who develop chronic or refractory ITP are at risk of ble
Autor:
Anam Khan, Atif Irfan Khan, Muhammad Ashar Ali, Nayha Tahir, Wajeeha Aiman, Arooj Devi, Mahwish Farrukh, Keren Thankam Sam, Muhammad Asad
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S228
Autor:
Anum Waqar, Sana Irfan Khan, Qasim Khurshid, Richi Kashyap, Faiz Anwer, Usman Akbar, Muhammad Ashar Ali, Atif Irfan Khan, Muhammad Ali Mirza, Sobia Aamir, Saad Ur Rahman, Anam Khan, Abdul Jabbar Dar
Publikováno v:
Blood. 136:22-23
Background Most children with Acute Lymphoblastic Leukaemia achieve complete remission and subsequent cure after chemotherapy. But, ALL relapse is the leading cause of treatment failure in paediatric patients, causing long term survival to below. Che
Autor:
Farhan Khalid, Sana Irfan Khan, Syeda Sabeeka Batool, Arshia Akbar, Seemal Iftikhar, Faiz Anwer, Atif Irfan Khan, Muhammad Ashar Ali, Abdul Jabbar Dar, Muhammad Tayyeb, Muhammad Yasir Anwar, Sobia Aamir, Anam Khan
Publikováno v:
Blood. 136:10-11
BACKGROUND: Acute Lymphoblastic leukemia (ALL) has good prognosis when treated with multiagent chemotherapy in pediatrics and young adolescents. Treatment of relapsed/refractory (R/R) ALL remains a challenge. Even after stem cell transplantation (SCT